Quantum BioPharma Q2 net loss narrows to USD 3.09 million; operating loss improves to USD 2.29 million - QNTM News | RalliesQuantum BioPharma Q2 net loss narrows to USD 3.09 million; operating loss improves to USD 2.29 million
Q
QNTM• Q2 and six-month results improve
- Quantum Biopharma posted a net loss of USD 16.85 million for the six months ended June 30, 2026, compared with USD 18.51 million a year earlier.
- Loss per share narrowed to USD 3.02 from USD 6.73 in the prior-year period.
- Cash used in operating activities improved to USD 3.46 million from USD 6.21 million in the prior-year period.
- Digital assets rose to USD 5.89 million at June 30, 2026, while cash and cash equivalents increased to USD 3.65 million.
- Trade and other payables declined to USD 3.38 million from USD 4.18 million at Dec. 31, 2025.
•
